Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombophilia × Injections × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 69 Breast Neoplasms 52 Neoplasms 27 Myelodysplastic Syndromes 27 Carcinoma, Non-Small-Cell Lung 27 Advanced Solid Tumor 27 Advanced Solid Tumors 26 Prostatic Neoplasms 24 Stomach Neoplasms 19 Recurrence 18 Multiple Myeloma 18 Carcinoma, Hepatocellular 18 Neoplasm Metastasis 17 Ovarian Neoplasms 15 Lung Neoplasms 15 Pancreatic Neoplasms 14 Uterine Cervical Neoplasms 13 Solid Tumor 13 Sarcoma 13 Melanoma 13 Leukemia, Myelomonocytic, Chronic 13 Colorectal Neoplasms 11 Small Cell Lung Carcinoma 10 Lymphoma, Large B-Cell, Diffuse 10 Triple Negative Breast Neoplasms 9 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Esophageal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7

Interventions

enoxaparin sodium 1 Observation 1 Lead 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡